Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and equivalents		$ 2,801	$ 2,213
Accounts and other current receivables, net		1,691	1,731
Inventories		1,430	1,604
Prepaid expenses and other		602	855
Investment in Baxalta common stock			5,148
Current assets held for disposition		50	245
Total current assets		6,574	11,796
Property, plant and equipment, net		4,289	4,386
Other assets
Goodwill		2,595	2,687
Other intangible assets, net		1,111	1,349
Other		977	744
Total other assets		4,683	4,780
Total assets		15,546	20,962
Current liabilities
Short-term debt			1,775
Current maturities of long-term debt and lease obligations	[1]	3	810
Accounts payable and accrued liabilities		2,612	2,666
Current income taxes payable		126	453
Current liabilities held for disposition		3	46
Total current liabilities		2,744	5,750
Long-term debt and lease obligations	[1]	2,779	3,922
Other long-term liabilities		1,743	2,425
Equity
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2016 and 2015		683	683
Common stock in treasury, at cost, 143,890,064 shares in 2016 and 135,839,938 shares in 2015		(7,995)	(7,646)
Additional contributed capital		5,958	5,902
Retained earnings		14,200	9,683
Accumulated other comprehensive (loss) income		(4,556)	224
Total Baxter shareholders’ equity		8,290	8,846
Noncontrolling interests		(10)	19
Total equity		8,280	8,865
Total liabilities and equity		$ 15,546	$ 20,962

[1] Book values include any discounts, premiums and adjustments related to hedging instruments.